Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Jumped back in pre-market at 2.21
I've made some good coin flipping this thing lately.
That's what we need!
Some upward activity here.
LBIO
« Back to Stocks Summary
Lion Biotechnologies Announces Positive Data From a TIL-Ipilimumab Combination Study in Melanoma
59 minutes ago - DJNF
Lion Biotechnologies Announces Positive Data From a TIL-Ipilimumab Combination Study in Melanoma
LOS ANGELES, March 30, 2015 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (Nasdaq:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor infiltrating lymphocytes (TIL), today announced that researchers from Moffitt Cancer Center reported positive results from a pilot trial of TIL and ipilimumab in patients with metastatic melanoma. The data from the trial, which Lion partially sponsored, were presented at the Society of Surgical Oncology 2015 meeting in Houston, TX on Friday, March 27, 2015.
The Phase 1 trial was conducted at Moffitt Cancer Center in 12 patients with metastatic melanoma, with the objective of determining the safety and feasibility of combining TIL therapy with the CTLA-4 checkpoint inhibitor, ipilimumab. Patients were treated with ipilimumab one week prior to tumor harvest for TIL expansion, a second time while their TIL were being expanded, and two more times following TIL transfer.
"Ipilimumab has potential to enhance the effectiveness of TIL therapy by boosting the concentration of tumor-reactive T cells in the tumors of patients prior to TIL harvest, and by controlling disease before TIL transfer," said Sangeetha Prabhakaran, MD, the study's presenting author. "Based on the results of this study, we conclude that TIL-ipilimumab combination treatment is both safe and feasible. Furthermore, this approach serves as a model for future efforts to combine TIL with PD-1/PD-L1 blockade and other emerging immune checkpoint inhibitors."
Amod Sarnaik, MD, a surgical oncologist at Moffitt and assistant professor of surgery at the University of South Florida, added, "This is the first report of TIL therapy being combined with checkpoint blockade therapy. These results are clinically significant because they show that checkpoint blockade can be safely combined with TIL therapy, potentially increasing the clinical benefit of this promising treatment modality for unresectable metastatic melanoma."
LBIO
Lion Biotechnologies Announces Positive Data From A TIL-Ipilimumab Combination Study In Melanoma *
Monday 03/30/2015 06:00 AM ET - Dow Jones News
I bought another block too
Lol
Only half?
For a lethal disease that is 100% fatal.
Too funny when dealing with non-medical personnel
Wow!!!
Last few days have been brutal here
Good call
Should be enough to push the share price up but its a down day in the market again today
Mine too.
Good day to be buying cheap shares tho.
Why the drop?
CUR
Time to re-visit this one.
Good science and good results.
Should be ready for the next leg up, IMO
LBIO
Bamb!!!
LBIO
I like LBIO down here after retrace.
Looking for the next leg up.
I know.
I'm with you here.
Hope you are correct in BIAD, just no volume here yet.
CUR
Should be about ready for next leg up IMO
I'm expecting it to climb into the summer
Jumped back in here again on the dip today
Great buying opportunity.
So you don't give Harvoni to hep C patients on Amiodorone.
Fairly simple. It should not affect sales much.
IMO, this is typical market over-reaction.
Futures are above $46 as I type.
Looks like we gap up in the pre-market tomorrow.
Jumped back in here just now on the dip
I just jumped back in pre-market at $1.93
I bought the dip the other day at $1.82 and sold at $2.15
I only bought back half my shares this AM
We shall see.
We are consolidating here now for a few days.
We have good data.
IMO, we move higher into the weekend.
We shall see
I just bought some of those .25's
LBIO
Has been big for me.
Took profits this AM
I have a big position in CUR at 2.22 average share price.
Keep an eye on it!
CUR
Keep an eye on this one.
Good science and great market.
Way oversold. Should bounce into the next two quarters IMO.
Me too.
I bought it at 1.82 and sold most at 2.15!
Counting on it
Great potential here.
Added to my position this AM
I have HRTX since 9's and holding for $20 PT
I'm in CUR. Great science! Big potential.
New here but I just had to pick up some cheapie pre-market shares at 2.41!
Will add more on any further weakness.
I just bought it at 3.41
now it's just emotional selling.
This is still a very good stock.
Hard to believe people are dumping at huge losses when this will likely bounce very nicely, IMO
yes, but $35 is a gift!!!
This is going back to high $30's very quickly
Just picked up some .228's
Agreed
Blue light special today.
Almost everything is on sale rack today
Just bought the dip here at $99.71
Looking good here